• News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • FREE newsletter subscription
  • Search
  • Menu Menu
International Hospital
  • AI
  • Cardiology
  • Oncology
  • Neurology
  • Genetics
  • Orthopaedics
  • Research
  • Surgery
  • Innovation
  • Medical Imaging
  • MedTech
  • Obs-Gyn
  • Paediatrics

Archive for category: E-News

E-News

Exercise can tackle symptoms of schizophrenia

, 26 August 2020/in E-News /by 3wmedia

Aerobic exercise can significantly help people coping with the long-term mental health condition schizophrenia, according to a new study from University of Manchester researchers.

Through combining data from 10 independent clinical trials with a total of 385 patients with schizophrenia, Joseph Firth found that around 12 weeks of aerobic exercise training can significant improve patients’ brain functioning.

The study was by Firth, Dr Brendon Stubbs and Professor Alison Yung.

Schizophrenia’s acute phase is typified by hallucinations and delusions, which are usually treatable with medication.

However, most patients are still troubled with pervasive cognitive deficits’; including poor memory, impaired information processing and loss of concentration.

The research showed that patients who are treated with aerobic exercise programs, such as treadmills and exercise bikes, in combination with their medication, will improve their overall brain functioning more than those treated with medications alone.
The areas which were most improved by exercising were patients’ ability to understand social situations, their attention spans, and their working memory’ – or how much information they can hold in mind at one time.

There was also evidence among the studies that programs which used greater amounts of exercise, and those which were most successful for improving fitness, had the greatest effects on cognitive functioning.

Joe Firth said: ‘Cognitive deficits are one aspect of schizophrenia which is particularly problematic.

‘They hinder recovery and impact negatively upon people’s ability to function in work and social situations. Furthermore, current medications for schizophrenia do not treat the cognitive deficits of the disorder.

‘We are searching for new ways to treat these aspects of the illness, and now research is increasingly suggesting that physical exercise can provide a solution.’

He added: ‘These findings present the first large-scale evidence supporting the use of physical exercise to treat the neurocognitive deficits associated with schizophrenia.

‘Using exercise from the earliest stages of the illness could reduce the likelihood of long-term disability, and facilitate full, functional recovery for patients.’

University of Manchester www.manchester.ac.uk/discover/news/exercise-can-tackle-symptoms-of-schizophrenia/

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:032020-08-26 14:38:18Exercise can tackle symptoms of schizophrenia

Non-narcotic nerve block controls children’s pain

, 26 August 2020/in E-News /by 3wmedia

A congenital condition called pectus excavatum, in which a child’s breastbone is sunken into the chest, can be corrected through minimally invasive surgery, but pain control after the operation can be a challenge. A Mayo Clinic study has found an effective way to control pain and reduce opioid painkiller use after surgery: sending children home with catheters that infuse a non-narcotic nerve-blocking drug called a paravertebral blockade. Use of the blocks shortens hospital stays and reduces opioid use after surgery, the researchers discovered.
The study focused on pain control after children receive a Nuss procedure, in which small incisions are made and a stainless steel or titanium bar is placed under the sternum to reshape the chest wall. Researchers looked at the cases of 132 children who had Nuss surgery from 2010 through 2015. Of those, 114 received paravertebral catheters and continued receiving the infusions for two to five days after returning home. Eighteen were instead given an epidural.
Use of paravertebral catheters cut the median hospital stay by roughly a day and a half from 120 hours to 80 hours, the researchers found. Opioid painkiller consumption also decreased. Opioids can have significant side effects that slow recovery after surgery, including drowsiness, light-headedness, nausea, constipation and risk of falls.
‘Our operation is minimally invasive, but it produces major changes in the chest wall. Pain was an issue for our patients, but this new technique has solved the problem. It’s better than an epidural, because it’s reliable, and kids can go home with it. For the first time, we consistently deliver on our promise to minimize pain,’ says co-author Christopher Moir, M.D., a pediatric and thoracic surgeon in the Mayo Clinic Children’s Center.
Chest wall deformities are fairly common. Pectus excavatum, also called funnel chest, is the most frequent. The sunken breastbone is noticeable when a child is born and typically worsens during the adolescent growth spurt. Even mild cases can cause children to feel self-conscious. Severe cases can interfere with heart and lung function.
Epidurals have been a standard method to manage pain after pectus excavatum surgery, but they are stopped before children leave the hospital, and severe pain may persist after that. Many hospitals, including Mayo Clinic, have been using other options, such as nerve blocks, patient-controlled painkiller delivery and non-narcotic painkiller injections. There has been little consistent data on pain outcomes.
‘This study puts solid data to what we see each day in the hospital and what families tell us. Paravertebal catheters work,’ Dr. Moir says.

Mayo Clinichttp://tinyurl.com/zqbbaz5

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:032020-08-26 14:38:26Non-narcotic nerve block controls children’s pain

Siemens and Dutch hospital ADRZ to jointly build and manage new operating theatres

, 26 August 2020/in E-News /by 3wmedia

Dutch hospital Admiraal De Ruyter Ziekenhuis (ADRZ), based in Goes, and Siemens Healthineers have signed an agreement to build and supply equipment for six operating theatres, including a hybrid OR. Siemens will build the new building complex with its partner companies Engie and Jan Snel. Under a Managed Equipment Service (MES) agreement, Siemens will also equip the new operating theatres with medical systems and service and update the equipment for ten years. Once the construction work is completed, Siemens will act as lessor, leasing both the new building and the medical systems to ADRZ. This model will enable ADRZ to handle a major investment without providing too high financing capital.
Earlier this year, the hospital operator and Siemens have entered into a similar agreement to build ADRZ’s new Nuclear Medicine Centre in Goes. Also in this case, Siemens will be involved in the construction and will supply the medical systems on an MES basis.
With 2,200 employees and 23,000 hospitalizations annually, ADRZ is the biggest hospital in the Zeeland Province in the southern part of the Netherlands. The new complex housing six operating theatres should be completed in February 2017. The total project cost is more than EUR 10 million.
All the theatres are set up the same, which in turn results in uniform running lines and logical order. For a surgeon, it makes no difference in which operating theatre he or she is working; every room is set up the same way. This also applies for the medical equipment. This set-up is supposed to provide for best possible patient safety and to support the medical staff to achieve the highest possible medical outcome.
‘This is a next step in upgrading the care infrastructure at ADRZ. After a period of austerity and reorientation this is literally and figuratively the next building block of the new ADRZ. We are delighted with our partner Siemens, who is supporting us in developing and implementing such a technically complex infrastructure. In this case it involves six operating theatres, whereby quality and safety for our patients are key aspects,’ said Claudia Brandenburg, Chairperson of the Board of Directors of ADRZ.
‘We at Siemens Healthineers intend to be the enabler for our healthcare partners. For this, our partnership with ADRZ is an excellent example: with our customized, long-term MES partnership, we enable ADRZ to continuously take advantage of state-of-the-art technology and processes within an affordable model. At the same time, ADRZ is able to concentrate on its medical core competence. By this collaborative model, we jointly drive operational performance and ultimately patient outcomes,’ said Sourabh Pagaria, Head of Enterprise Services at Siemens Healthineers.

www.siemens.com
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:032020-08-26 14:38:05Siemens and Dutch hospital ADRZ to jointly build and manage new operating theatres

New recommendations to reduce radiation risk from digital screening mammography

, 26 August 2020/in E-News /by 3wmedia

Radiation-induced breast cancer risk from digital mammography is low for the majority of women, but risk is higher in women with large breasts, who received 2.3 times more radiation and required more views per examination to image as much of the breast as possible compared to those with small or average-sized breasts.
The study also found that screening every two years instead of annually, and beginning at age 50 instead of 40 or 45, lowers the likelihood of radiation-induced breast cancer in all women. The findings from a team of researchers include Rebecca Hubbard, PhD, an associate professor of Biostatistics in Biostatistics and Epidemiology in the Perelman School of Medicine at the University of Pennsylvania.
In eight screening strategies estimated using two models, the group simulated the lifetime risk of women developing radiation-induced breast cancer from digital screening mammography and dying from the disease compared to the number of deaths averted through early detection.
The group found that screening 100,000 women, ages 50 to 74, every two years, prevented 627 deaths. The radiation exposure from these screening exams, and any subsequent diagnostic work-ups, caused 27 breast cancer cases and 4 breast cancer deaths. Although screening 100,000 women annually from 40 to 74 years prevented 968 deaths, it also raised cancer risk five-fold, causing 100 additional radiation-induced breast cancers and 12 additional breast cancer deaths compared with screening every two years from age 50 to 74.
Recommendations released recently by the U.S. Preventive Services Task Force, an independent panel appointed by the federal government, echo the study’s finding that women between the ages of 50 and 74 should be screened once every two years for breast cancer.
‘Choosing a screening schedule that reduces harms while maintaining the benefits of more frequent screening makes screening mammography safer for all women,’ Hubbard, who is also senior author on the study, said. ‘As our understanding of the effects of individual characteristics on harms and benefits of mammography grows, we can more effectively tailor screening strategies to minimize harms and save more lives.’
While not explicitly reviewed in the research, the findings suggest risk is also higher in those with breast implants, which require twice as many views during mammography, and/or denser breasts which require additional evaluations resulting in more radiation exposure.
The study also noted that obtaining fewer mammograms would also result in fewer false positives, which can prevent radiation exposure from possibly unneeded follow-up diagnostic mammograms.

Perelman School of Medicine http://tinyurl.com/jqfej6z

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:032020-08-26 14:38:13New recommendations to reduce radiation risk from digital screening mammography

Triple-therapy patch delivers local treatment, prevents recurrence in colon cancer model

, 26 August 2020/in E-News /by 3wmedia

Investigators at Brigham and Women’s Hospital have developed a hydrogel patch that can adhere to tumours in a preclinical model of colon cancer, delivering a local, combination treatment as the elastic gel breaks down over time. The new technique may allow clinicians to someday use diagnostic colonoscopy equipment to immediately deliver treatment without the need for open surgery at a later date.

The researchers were able to deliver three therapeutic strategies in their mouse model of colon cancer: gene therapy, chemotherapy or thermal ablation or a combination of all three. The team used gold nanoparticles to deliver a gene therapy treatment that targets Kras, a known cancer gene, and used near-infrared radiation to release a chemotherapeutic and cause heat damage to the cancer cells. The local, triple-combination therapy not only shrank tumours but also had a sustained effect overtime, preventing tumour recurrence and significantly extending survival of mice.

The researchers examined the effects of the therapy both with and without resection (surgical removal of the tumour), which is the current standard treatment for colon cancer in humans. In human cases where resection is not possible, a neoadjuvant therapy, such as chemotherapy or radiation therapy, is often used to shrink tumours before clinicians attempt to remove them. Natalie Artzi, PhD senior author of the study and a principal investigator at BWH, and her colleagues anticipate that their hydrogel patch could someday be used to shrink tumours before resection or could eliminate the need for resection entirely. They plan to test the material in larger preclinical models and dive more deeply into the genetic changes resulting from therapy to pinpoint which genes are most critical to target.

Brigham and Women’s Hospital www.brighamandwomens.org/about_bwh/publicaffairs/news/pressreleases/PressRelease.aspx?PageID=2459

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:032020-08-26 14:38:20Triple-therapy patch delivers local treatment, prevents recurrence in colon cancer model

Device to monitor fetal oxygen levels

, 26 August 2020/in E-News /by 3wmedia

Rice University students have created a prototype of a device to monitor the pulse and oxygen levels of a fetus undergoing endoscopic fetal surgery in a mother’s womb.
The WombOx team of senior engineering students worked in close collaboration with the Texas Children’s Fetal Center to create their device, which miniaturizes the components found in a pulse oximeter commonly clipped to a patient’s finger in a doctor’s office.
Pulse oximeters ‘see’ oxygen levels in the blood by comparing light from a source to the light that reaches a detector on the other side of the finger. The instrument can calculate oxygen saturation by how much light it senses is absorbed by the tissue.
That kind of information hasn’t been available to doctors working to help fetuses suffering from congenital defects such as spina bifida, the incomplete closure of the backbone around the spinal cord.
Texas Children’s Hospital is pioneering efforts to treat such conditions through the endoscopic procedure known as fetoscopic surgery. During surgery, doctors are able to monitor the health of a fetus through ultrasound, but that only gives them a basic heartbeat. Knowing oxygen levels in the blood is critical when doctors need to act quickly to help a fetus in distress, and the WombOx device shows potential for providing such data in real time.
To build the prototype, the bioengineering students, Claudia Iriondo, Thomas Loughlin, Samir Saidi and Kathryn Wallace, worked closely with Dr. Magdalena Sanz Cortes, an associate professor of obstetrics and gynecology at Baylor College of Medicine and a clinician at the Texas Children’s Pavilion for Women, as well as their Rice faculty adviser, engineering lecturer Eric Richardson. It is the product of their capstone design project, required of most senior engineering students at Rice.
A few weeks after winning the top Willy Revolution Award, a $5,000 prize presented at Rice’s annual Engineering Design Showcase for innovation in design, and days before commencement, the team spent a morning in a device-testing suite at the Pavilion for Women to watch their prototype in action.
‘This project was challenging because of the size of the instruments that we work with,’ Sanz Cortes said. ‘When we started talking about the whole project, we talked about the size of a pulse oximeter. Transforming that into the size of the device they have created is very challenging.
‘The other challenging part was the mechanics, how to design something that is safe enough for the baby and can be compatible with our surgeries. It’s not a trivial matter, and they did a great job,’ she said.
At first glance, the device is a loop of wire on a hollow stick. But a closer look reveals that the wire is a special hybrid that expands to a predetermined shape at the correct temperature. It carries LEDs and a photodetector on miniature circuit boards that illuminate and sense the flow of blood through the tissue underneath.
The loop is packaged in a retractable sheath that fits through the small incision made in fetoscopic surgeries. The WombOx device is used like all other endoscopic tools, with a miniature camera. The idea is to insert the tube into the mother’s womb and extend the loop. Once it expands, doctors use the video feed to guide the loop around a limb and gently tighten it, putting the sensors in place to monitor the fetus throughout the surgical procedure.
‘Our design, like other endoscopic tools, is intended for single use,’ Iriondo explained. The device is durable enough to withstand unsheathing, expansion in the womb, attachment to the fetus and resheathing during removal.’

Rice University http://tinyurl.com/z3p6dmc

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:032020-08-26 14:38:07Device to monitor fetal oxygen levels

Novel approach improves symptoms of hazardous lymph blockage

, 26 August 2020/in E-News /by 3wmedia

Paediatric researchers have devised an innovative, safe and minimally invasive procedure that helps relieve rare but potentially life-threatening airway blockages occurring in children who had surgery for congenital heart defects.
The physician-researchers developed new imaging tools and used minimally invasive catheterization techniques to treat plastic bronchitis, a condition in which abnormal circulation causes lymphatic fluid to dry into solid casts that clog a child’s airways.
The study, which describes the pathophysiological mechanism of plastic bronchitis and a treatment approach, arose from collaboration between Maxim Itkin, MD, an associate professor of Radiology in the Perelman School of Medicine at the University of Pennsylvania, and Yoav Dori, MD, a pediatric cardiologist in the Cardiac Center at The Children’s Hospital of Philadelphia (CHOP). They co-lead a specialized team dedicated to the care of lymphatic disorders as part of the Center for Lymphatic Imaging and Interventions at The Children’s Hospital of Philadelphia and the Hospital of the University of Pennsylvania.
‘This is a new treatment option for children with plastic bronchitis and has the potential to offer long-term improvement of this condition,’ said Dori. ‘This procedure may even provide cure and avoid the need for a heart transplant.’
The current study builds on the team’s 2014 article in Pediatrics, the first case report of the successful use of their technique in a patient with plastic bronchitis. ‘We have expanded on that study to report short-term outcomes in a larger group and to share insights into the development of plastic bronchitis, which has been poorly understood,’ said Itkin. In addition to heart patients, children and adults with idiopathic plastic bronchitis, in which the cause is unknown, have also been treated successfully using these techniques.
Itkin and Dori discovered that the primary cause of plastic bronchitis is a lymphatic flow disorder, due to abnormal lymphatic flow into lung tissue. Because physical examinations and conventional imaging may not provide specific findings, lymphatic flow disorders often go undiagnosed.
Over the past several years, Itkin and Dori developed a customized form of magnetic resonance imaging (MRI), called dynamic contrast enhanced MR lymphangiogram, to visualize the anatomy and flow pattern of a patient’s lymphatic system. This technique allows clinicians to locate the site at which lymph leaks into the airways.
Plastic bronchitis may occur in children as a rare complication of early-childhood heart surgeries used for single-ventricle disease, in which one of the heart’s pumping chambers is severely underdeveloped. Approximately 5 percent of children surviving this surgery experience plastic bronchitis because the surgery alters venous and lymphatic pressure. The authors argue that this altered pressure may interact with pre-existing anatomical differences in the patients’ lymphatic vessels.
The abnormal circulation causes lymph to ooze backward into a child’s airways, drying into a caulk-like cast formation that takes the shape of the airways. The first sign of plastic bronchitis may be when a child coughs out the cast. However, if unable to cough it up, a child may suffer fatal asphyxiation.
After identifying the leakage site in a lymphatic vessel, the lymphatic team intervenes, using a technique called lymphatic embolization. Through small catheters, the team blocks the abnormal flow with a variety of tools: coils, iodized oil, and covered stents, based on an individual patient’s needs.
In the current report, the team was able to perform lymphatic embolization in 17 of their 18 patients, ranging from age 2 to age 15 (median age 8.6 years). Fifteen of those 17 patients had significant improvements in cast formation, in some cases being cast-free longer than two years. Patients had transient side effects of abdominal pain and hypotension (low blood pressure), but the authors reported the procedure appeared safe in their patient group.

The Children’s Hospital of Philadelphia http://tinyurl.com/hjr4jps

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:032020-08-26 14:38:15Novel approach improves symptoms of hazardous lymph blockage

Computational modelling can predict onset and progression of knee osteoarthritis in overweight people

, 26 August 2020/in E-News /by 3wmedia

Computational modelling makes it possible to predict the onset and progression of knee osteoarthritis in overweight people, shows a new study from the University of Eastern Finland. A computational model based on the degradation of the collagen fibril network in the articular cartilage was able to predict the onset and progression of osteoarthritis in overweight people during a four-year follow-up. In normal-weight people, osteoarthritis did not develop within this time span.

The study also developed a model of the knee joint which makes it possible to evaluate the mechanical responses experienced by cartilage cells in healthy and osteoarthritic cartilage during daily activities such as walking. The model demonstrated that both menisectomy and osteoarthritic changes to the cartilage cause significant alterations in cartilage cell responses.

Osteoarthritis is a joint disease estimated to affect around 5% of the total world population. Osteoarthritis is the most common in the knee or hip joint and it often develops as a result of ageing, but it can also develop due to excessive loading or joint injury. In Europe, over 100 million people have arthritis, and in America, direct costs of arthritis were $51.1 billion in 2004. In addition, it has been predicted that the number of patients with knee osteoarthritis increases by 40% by the end of 2050.

Osteoarthritis proceeds gradually, weakening the articular cartilage and ultimately wearing it off completely from the ends of articulating bones. In these cases, the patient suffers from heavy joint pain and the joint becomes stiff, often leading to incapacity for work. Joint replacement surgery is the only effective treatment for osteoarthritis, which is why the prevention of osteoarthritis would be a cost-effective alternative both for the patient and society at large.

The study utilised a computational modelling method integrating the tissue and cellular levels of the articular cartilage in order to analyse the function of the articular cartilage during the onset and progression of osteoarthritis. The method simulated the effect of articular cartilage composition, structure and various loadings on the volume, shape and mechanical responses of cartilage cells.

Compared to healthy cartilage, the cell volume of osteoarthritic cartilage increased as a result of mechanical loading. The modelling indicated that the most important explanatory factors for the cell volume increase were the pericellular fixed charge density, i.e. the number of proteoglycan molecules, and the stiffness of the collagen fibril network.

The study also analysed the effect of menisectomy, a commonly used method in knee surgery, and simulated overweight on cell responses. Both menisectomy and simulated overweight substantially increased fluid pressures in the cell and cartilage tissue during walking, but they did not have an effect on the cell shape or volume in healthy cartilage. In osteoarthritic cartilage, however, cells were compressed and elongated more, probably due to altered cartilage integrity.

During standing, the strains were amplified more in the cell than in pericellullar tissue in healthy joint cartilages, but the opposite was observed in osteoarthritic joint cartilage. It is possible that the pericellular tissue’s function is to protect cartilage cells from sudden changes and to promote cartilage health.

The study also developed computational algorithms for the degradation of the collagen fibril network in the articular cartilage and its reorganisation in order to predict the development and progression of osteoarthritis caused by overweight and cartilage damage. The estimate obtained from the degradation algorithm was well in line with the clinically observed progression of osteoarthritis during a four-year follow-up. Furthermore, the collagen fibril network structure in the mechanically injured cartilage was observed to be disorganised in the vicinity of the injury, suggesting that a cartilage injury exposes cartilage to further damage.

In-depth understanding of the effects of abnormal loading, early osteoarthritis and mechanical injuries on cellular and tissue responses in cartilage makes it possible to develop new strategies for the recognition, prevention and slowing down the progression of the disease. The methods developed in the study may become widespread in specialised health care in the future. However, rigorous clinical validation will be necessary before they can be introduced to clinical use.

University of Eastern Finlandwww.uef.fi/-/computational-modelling-can-predict-onset-and-progression-of-knee-osteoarthritis-in-overweight-people

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:032020-08-26 14:38:23Computational modelling can predict onset and progression of knee osteoarthritis in overweight people

Healing little hearts with the aid of Sonosite point-of-care ultrasound

, 26 August 2020/in E-News /by 3wmedia

Surgical teams from the UK-based charity Healing Little Hearts are using the NanoMaxx point-of-care ultrasound to help accelerate recoveries and improve outcomes for pediatric patients with congenital heart defects. Healing Little Hearts provides life-saving heart operations to babies and children across India who would not otherwise have access to treatment, as well as helping to develop local pediatric surgical programmes. Dr Sanaulla Syed, a pediatric cardiac anesthetist with the charity, commented: ‘Obtaining vascular access in small children can be difficult, and the availability of point of care ultrasound systems has revolutionized this practice. As the technology has improved, this has led to other applications, and we now use ultrasound for a range of diagnostic applications before, during and after cardiac surgery. Ultrasound-guided regional anesthesia – specifically bilateral paravertebral blocks – can also significantly reduce the amount of opiates required for surgery, considerably shortening post-operative recovery times and offering improved analgesia.’

www.sonosite.com

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:032020-08-26 14:38:10Healing little hearts with the aid of Sonosite point-of-care ultrasound

Prescription drug abuse epidemic extends beyond the United States

, 26 August 2020/in E-News /by 3wmedia

There is a high rate of prescription pain reliever abuse in Europe, largely accounted by opioids, according to the first comparative study of prescription drug abuse in the European Union, which was conducted by researchers at RTI International.

The study investigated nonmedical prescription drug use in five European countries – Denmark, Germany, Spain, Sweden and the United Kingdom.

‘For certain classes of medications, like opioids, we found a significant rate of prescription pain reliever abuse in the EU,’ said Scott Novak, Ph.D., lead author of the study and senior development epidemiologist at RTI. ‘While the lifetime rates were not as high as in the U.S. – 20 percent for those aged 12 years and over, compared to between 7 percent and 13 percent in the EU – the past-year rates were only slightly lower. This suggests that the EU may be catching up to the United States for some substances.’

Nonmedical prescription drug use is typically defined as either the self-treatment of a medical condition using prescription medication that was not prescribed to the user, or as the use of prescription medication to achieve euphoric states. Nonmedical prescription drug use is among the leading public health issues in the United States and previous research has suggested that it is more widespread in the United States than in Europe, where prevalence and user characteristics remain largely unknown.

‘Previously, it was thought that the prescription drug epidemic was limited to the United States,’ Novak said, ‘but this study shows that the epidemic extends well beyond the U.S.’

Examining three different classes of subscription drugs – opioids, sedatives and stimulants – the researchers found that out of the five countries examined, Germany had the lowest levels of nonmedical prescription drug use, while the U.K., Spain and Sweden had the highest levels.

The most common sources of prescription drugs for nonmedical use were family and friends – 44 percent for opioids and 62 percent for sedatives. The next most common source was taking drugs from another person without their knowledge. Internet purchases were the least common source of prescription drugs.

Nonmedical prescription drug use was more common among men relative to women, among white relative to non-white people, and among those who were unemployed compared with other levels of employment. Young people aged 12 to 17 years were at lower risk of nonmedical prescription drug use than people aged 18 years or older.

Having been prescribed a pain reliever was associated with an eight times higher risk of subsequent nonmedical use of prescription pain relievers. The risk was ten times higher for sedatives and seven times higher for stimulants.

The researchers also found that about 52 percent of nonmedical stimulant users, 32 percent of nonmedical opioid users and 28percent of nonmedical sedative users also consumed illicit drugs – this is known as poly-drug use. Rates of poly-drug use involving either sedatives or opioids were highest in the U.K. – 48 percent for sedatives and 43 percent for opioids. Women were about half as likely to engage in poly-drug use as men. Suffering from serious psychological distress, having a sexually transmitted disease and having a history of childhood arrest were also associated with a higher risk of poly-drug use.

The study suggests that international collaborations across Europe are needed to monitor prescription drug abuse, identify its scope and develop targeted interventions.

Identification of the scope and prevalence of nonmedical prescription drug use in the EU is an important first step in building a worldwide system that can be used to monitor trends, track risk and protective factors and to develop targeted interventions aimed at reducing the risk of nonmedical prescription drug use, according to the researchers.

The authors caution that their findings should not be construed as recommendation against prescribing medications to treat legitimate conditions. The cross-sectional design of this study made it impossible to resolve the question if nonmedical prescription drug use serves as a gateway to other substances or if persons using illicit drugs are at higher risk for also using prescription drugs to self-treat or to achieve euphoria.

RTI International www.rti.org/news/prescription-drug-abuse-epidemic-extends-beyond-united-states

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:032020-08-26 14:38:18Prescription drug abuse epidemic extends beyond the United States
Page 177 of 240«‹175176177178179›»

Latest issue of International Hospital

April 2024

7 January 2026

Gulf Aorta Summit 2026 Returns to Dubai with a Global Lineup of Aortic Experts

17 December 2025

GE HealthCare receives CE mark for 128cm total body PET/CT

16 December 2025

HOPS 2026 Returns to Dubai — Setting a New Benchmark for Oncology Pharmacy in the Middle East

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The medical devices information portal connecting healthcare professionals to global vendors

Sign in for our newsletter
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Media kit
    • Submit Press Release

Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@interhospi.com

PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Sign in for our newsletter

Free subscription